19-12738573-C-G
Variant names:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_004317.4(GET3):c.224C>G(p.Pro75Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
GET3
NM_004317.4 missense
NM_004317.4 missense
Scores
16
2
1
Clinical Significance
Conservation
PhyloP100: 7.40
Genes affected
GET3 (HGNC:752): (guided entry of tail-anchored proteins factor 3, ATPase) This gene represents the human homolog of the bacterial arsA gene, encoding the arsenite-stimulated ATPase component of the arsenite transporter responsible for resistance to arsenicals. This protein is also a central component of a transmembrane domain (TMD) recognition complex (TRC) that is involved in the post-translational delivery of tail-anchored (TA) proteins from the cytosol to the endoplasmic reticulum (ER). It recognizes and selectively binds the TMD of TA proteins in the cytosol, and delivers them to the ER for insertion. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GET3 | NM_004317.4 | c.224C>G | p.Pro75Arg | missense_variant | Exon 2 of 7 | ENST00000357332.8 | NP_004308.2 | |
GET3 | NM_001371488.1 | c.224C>G | p.Pro75Arg | missense_variant | Exon 3 of 8 | NP_001358417.1 | ||
GET3 | NM_001371489.1 | c.224C>G | p.Pro75Arg | missense_variant | Exon 3 of 8 | NP_001358418.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GET3 | ENST00000357332.8 | c.224C>G | p.Pro75Arg | missense_variant | Exon 2 of 7 | 1 | NM_004317.4 | ENSP00000349887.3 | ||
GET3 | ENST00000591090.5 | c.224C>G | p.Pro75Arg | missense_variant | Exon 3 of 8 | 5 | ENSP00000466379.1 | |||
GET3 | ENST00000590633.1 | n.233C>G | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Prostate cancer Uncertain:1
-
Prostate Cancer Research Center, Institute of Biosciences and Medical Technology, University of Tampere
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.;M;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;.;D;.
REVEL
Pathogenic
Sift
Pathogenic
.;.;D;.
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;.;D;.
Vest4
MutPred
Gain of catalytic residue at P75 (P = 0.0344);Gain of catalytic residue at P75 (P = 0.0344);Gain of catalytic residue at P75 (P = 0.0344);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at